Get started
Author

Arsalan S. Haqqani

Observed names: A. S. Haqqani, A.S. Haqqani, Arsalan Haqqani, Arsalan S Haqqani, Haqqani, Arsalan, Haqqani, Arsalan S, Haqqani, Arsalan S.
Observed institutions: Montreal Neurological Institute and Hospital, University of Ottawa, Douglas Mental Health University Institute, Institute for Biological Sciences, Institut Universitaire de Gériatrie de Montréal, National Research Council Canada, McGill University, Université de Montréal
ORCID: 0000-0003-2454-8989
Observed ORCID: 0000-0003-2454-8989
OpenAlex ID: A5003550473
Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system
2007 · Romain Cayrol, Karolina Wosik, et al. · Nature Immunology · 442
Differential expression of receptors mediating receptor-mediated transcytosis (RMT) in brain microvessels, brain parenchyma and peripheral tissues of the mouse and the human
2020 · Wandong Zhang, Qing Yan Liu, et al. · Fluids and Barriers of the CNS · 198
PDF
Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells
2013 · Arsalan S Haqqani, Christie E Delaney, et al. · Fluids and Barriers of the CNS · 197
PDF
Role of ninjurin‐1 in the migration of myeloid cells to central nervous system inflammatory lesions
2011 · Igal Ifergan, Hania Kebir, et al. · Annals of Neurology · 167
Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteria
2024 · Arsalan S. Haqqani, Kasandra Bélanger, et al. · Frontiers in Drug Delivery · 157
PDF
A novel platform for engineering blood‐brain barrier‐crossing bispecific biologics
2014 · Graham K. Farrington, Nadia Caram‐Salas, et al. · The FASEB Journal · 148
PDF
A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis
2018 · Maria Ribecco-Lutkiewicz, Caroline Sodja, et al. · Scientific Reports · 146
PDF
Characterization of vascular protein expression patterns in cerebral ischemia/reperfusion using laser capture microdissection and ICAT‐nanoLC‐MS/MS
2005 · Arsalan S. Haqqani, Momir Nesic, et al. · The FASEB Journal · 125
Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood–brain barrier in vitro is dependent on its binding affinity
2018 · Arsalan S. Haqqani, George Thom, et al. · Journal of Neurochemistry · 96
PDF
Endosomal trafficking regulates receptor-mediated transcytosis of antibodies across the blood brain barrier
2017 · Arsalan S Haqqani, Christie E Delaney, et al. · Journal of Cerebral Blood Flow & Metabolism · 93
PDF
Biomarker potential of brain‐secreted extracellular vesicles in blood in Alzheimer's disease
2020 · AmanPreet Badhwar, Arsalan S. Haqqani · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · 87
PDF
Zika virus crosses an in vitro human blood brain barrier model
2018 · Judie B. Alimonti, Maria Ribecco-Lutkiewicz, et al. · Fluids and Barriers of the CNS · 87
PDF
Blood–brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics
2014 · Danica B Stanimirovic, Mahmud Bani-Yaghoub, et al. · Expert Opinion on Drug Discovery · 85
Expression of Interleukin-8 Promotes Neutrophil Infiltration and Genetic Instability in Mutatect Tumors
2000 · Arsalan S. Haqqani, Jagdeep K. Sandhu, et al. · Neoplasia · 85
PDF
Quantitative Protein Profiling by Mass Spectrometry Using Label-Free Proteomics
2008 · Arsalan S. Haqqani, John F. Kelly, et al. · Methods in molecular biology · 84
Brain penetration, target engagement, and disposition of the blood‐brain barrier‐crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1
2016 · Carl I. Webster, Nadia Caram‐Salas, et al. · The FASEB Journal · 81
Protein Biomarkers in Serum of Pediatric Patients with Severe Traumatic Brain Injury Identified by ICAT–LC-MS/MS
2007 · Arsalan S. Haqqani, James S. Hutchison, et al. · Journal of Neurotrauma · 75
Selective Nitration of Histone Tyrosine Residues in Vivo in Mutatect Tumors
2002 · Arsalan S. Haqqani, John F. Kelly, et al. · Journal of Biological Chemistry · 74
PDF
Enhanced Delivery of Galanin Conjugates to the Brain through Bioengineering of the Anti-Transferrin Receptor Antibody OX26
2018 · George Thom, Matthew Burrell, et al. · Molecular Pharmaceutics · 73
PDF
Functions of lipid raft membrane microdomains at the blood–brain barrier
2009 · Aurore Dodelet-Devillers, Romain Cayrol, et al. · Journal of Molecular Medicine · 70
Engineering and Pharmacology of Blood–Brain Barrier-Permeable Bispecific Antibodies
2014 · Danica Stanimirovic, Kristin Kemmerich, et al. · Advances in pharmacology · 68
Multiplexed Evaluation of Serum and CSF Pharmacokinetics of Brain-Targeting Single-Domain Antibodies Using a NanoLC–SRM-ILIS Method
2012 · Arsalan S. Haqqani, Nadia Caram-Salas, et al. · Molecular Pharmaceutics · 60
Targeting insulin‐like growth factor‐1 receptor (IGF1R) for brain delivery of biologics
2022 · Wael Alata, Alvaro Yogi, et al. · The FASEB Journal · 59
PDF
A Myeloperoxidase-Specific Assay Based upon Bromide-Dependent Chemiluminescence of Luminol
1999 · Arsalan S. Haqqani, Jagdeep K. Sandhu, et al. · Analytical Biochemistry · 57
Brain Delivery of IGF1R5, a Single-Domain Antibody Targeting Insulin-like Growth Factor-1 Receptor
2022 · Alvaro Yogi, Greg Hussack, et al. · Pharmaceutics · 52
PDF
Works count: 116
Citation count: 3,643
H-index: 33
I10-index: 50
Year
Topic
Type